Enforcement Trends: CMS Looks to Recover $66.3 Million in Improper Specimen Validity Test Payments

by Glenn S. Demby | Apr 1, 2019 | Enforcement-nir, National Lab Reporter

From – National Intelligence Report
The opioid crackdown has made urine drug testing an even greater priority for federal health fraud enforcers. One principle target is specimen validity testing…

. . . read more

This content is for Paid Members only.
Login Register

Enforcement Trends: CMS Looks to Recover $66.3 Million in Improper Specimen Validity Test Payments

Log In